BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

660 related articles for article (PubMed ID: 14571786)

  • 1. Analysis of the prognostic factors for liver metastasis of gastric cancer after hepatic resection: a multi-institutional study of the indications for resection.
    Shirabe K; Shimada M; Matsumata T; Higashi H; Yakeishi Y; Wakiyama S; Ikeda Y; Ezaki T; Fukuzawa S; Takenaka K; Kishikawa K; Ikeda T; Taguchi K; Maehara Y; Sugimachi K
    Hepatogastroenterology; 2003; 50(53):1560-3. PubMed ID: 14571786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological prognostic factors after hepatectomy for patients with mass-forming type intrahepatic cholangiocarcinoma: relevance of the lymphatic invasion index.
    Shirabe K; Mano Y; Taketomi A; Soejima Y; Uchiyama H; Aishima S; Kayashima H; Ninomiya M; Maehara Y
    Ann Surg Oncol; 2010 Jul; 17(7):1816-22. PubMed ID: 20135355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological features and outcome of hepatic resection for liver metastasis from gastric cancer.
    Saiura A; Umekita N; Inoue S; Maeshiro T; Miyamoto S; Matsui Y; Asakage M; Kitamura M
    Hepatogastroenterology; 2002; 49(46):1062-5. PubMed ID: 12143202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of hepatic resection for metachronous liver metastases from gastric cancer].
    Nashimoto A; Yabusaki H; Takii Y; Tsuchiya Y; Tanaka O
    Gan To Kagaku Ryoho; 2002 Nov; 29(12):2096-9. PubMed ID: 12484011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic results for hepatic metastasis of colorectal cancer with special reference to effectiveness of hepatectomy: analysis of prognostic factors for 763 cases recorded at 18 institutions.
    Kato T; Yasui K; Hirai T; Kanemitsu Y; Mori T; Sugihara K; Mochizuki H; Yamamoto J
    Dis Colon Rectum; 2003 Oct; 46(10 Suppl):S22-31. PubMed ID: 14530655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multivariate prognostic study on large gastric cancer.
    Shiraishi N; Sato K; Yasuda K; Inomata M; Kitano S
    J Surg Oncol; 2007 Jul; 96(1):14-8. PubMed ID: 17582596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenocarcinoma in the middle third of the stomach--an evaluation for the prognostic significance of clinicopathological features.
    Sheen-Chen SM; Chou CW; Chen MC; Chen FC; Chen YS; Chen JJ
    Hepatogastroenterology; 1997; 44(17):1488-94. PubMed ID: 9356878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prognostic factors for long-term outcome of hepatic resection for colorectal liver metastases].
    Aldrighetti L; Castoldi R; Di Palo S; Arru M; Stella M; Orsenigo E; Gavazzi F; Ferla G; Di Carlo V; Staudacher C
    Chir Ital; 2005; 57(5):555-70. PubMed ID: 16241086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of hepatic resection for synchronous liver metastasis from gastric cancer].
    Manba N; Nashimoto A; Yabusaki H; Nakagawa S; Nomura T; Maruyama S; Takii Y; Tsuchiya Y; Tanaka O
    Gan To Kagaku Ryoho; 2009 Nov; 36(12):2016-8. PubMed ID: 20037309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinicopathological analysis of synchronous liver metastasis in gastric cancer and evaluation of surgical outcomes].
    Li YM; Zhan WH; Han FH; He YL; Peng JS; Cai SR; Ma JP; Zhao G
    Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Mar; 9(2):127-30. PubMed ID: 16555151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of hepatectomy for patients with liver metastases of gastric cancer.
    Morise Z; Sugioka A; Hoshimoto S; Kato T; Ikeda M; Uyama I; Horiguchi A; Miyakawa S
    Hepatogastroenterology; 2008; 55(85):1238-41. PubMed ID: 18795664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver resection for metastatic gastric cancer: experience with 42 patients including eight long-term survivors.
    Koga R; Yamamoto J; Ohyama S; Saiura A; Seki M; Seto Y; Yamaguchi T
    Jpn J Clin Oncol; 2007 Nov; 37(11):836-42. PubMed ID: 17928333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Favorable indications for hepatectomy in patients with liver metastasis from gastric cancer.
    Sakamoto Y; Sano T; Shimada K; Esaki M; Saka M; Fukagawa T; Katai H; Kosuge T; Sasako M
    J Surg Oncol; 2007 Jun; 95(7):534-9. PubMed ID: 17219383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indication for hepatic resection in the treatment of liver metastasis from gastric cancer.
    Makino H; Kunisaki C; Izumisawa Y; Tokuhisa M; Oshima T; Nagano Y; Fujii S; Kimura J; Takagawa R; Kosaka T; Ono HA; Akiyama H; Tanaka K; Endo I
    Anticancer Res; 2010 Jun; 30(6):2367-76. PubMed ID: 20651395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymph node metastasis in early gastric cancer: a clinicopathological analysis.
    Wu CY; Chen JT; Chen GH; Yeh HZ
    Hepatogastroenterology; 2002; 49(47):1465-8. PubMed ID: 12239968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical resection of liver metastases of gastric cancer: an analysis of a 17-year experience with 22 patients.
    Sakamoto Y; Ohyama S; Yamamoto J; Yamada K; Seki M; Ohta K; Kokudo N; Yamaguchi T; Muto T; Makuuchi M
    Surgery; 2003 May; 133(5):507-11. PubMed ID: 12773978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indications for curative resection of advanced gallbladder cancer with hepatoduodenal ligament invasion.
    Endo I; Shimada H; Fujii Y; Sugita M; Masunari H; Miura Y; Tanaka K; Misuta K; Sekido H; Togo S
    J Hepatobiliary Pancreat Surg; 2001; 8(6):505-10. PubMed ID: 11956900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome of hepatic resection for metastatic gastric cancer.
    Roh HR; Suh KS; Lee HJ; Yang HK; Choe KJ; Lee KU
    Am Surg; 2005 Feb; 71(2):95-9. PubMed ID: 16022005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of microscopic hepatic lymph node involvement on survival after resection of colorectal liver metastasis.
    Laurent C; Sa Cunha A; Rullier E; Smith D; Rullier A; Saric J
    J Am Coll Surg; 2004 Jun; 198(6):884-91. PubMed ID: 15194069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors for radical resection of middle and distal bile duct cancer.
    Nomura T; Tsuchiya Y; Nashimoto A; Yabusaki H; Takii Y; Nakagawa S; Sato N; Kanbayashi C; Tanaka O
    Hepatogastroenterology; 2009; 56(90):294-8. PubMed ID: 19579585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.